JP2003514013A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003514013A5 JP2003514013A5 JP2001537935A JP2001537935A JP2003514013A5 JP 2003514013 A5 JP2003514013 A5 JP 2003514013A5 JP 2001537935 A JP2001537935 A JP 2001537935A JP 2001537935 A JP2001537935 A JP 2001537935A JP 2003514013 A5 JP2003514013 A5 JP 2003514013A5
- Authority
- JP
- Japan
- Prior art keywords
- buprenorphine
- naltrexone
- nalmefene
- naloxone
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 16
- 229960001736 buprenorphine Drugs 0.000 description 16
- WJBLNOPPDWQMCH-MBPVOVBZSA-N Nalmefene Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=C)O)CC1)O)CC1CC1 WJBLNOPPDWQMCH-MBPVOVBZSA-N 0.000 description 13
- 229960005297 nalmefene Drugs 0.000 description 13
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 13
- 229960004127 naloxone Drugs 0.000 description 13
- DQCKKXVULJGBQN-XFWGSAIBSA-N naltrexone Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)O)CC1)O)CC1CC1 DQCKKXVULJGBQN-XFWGSAIBSA-N 0.000 description 13
- 229960003086 naltrexone Drugs 0.000 description 13
- 239000002552 dosage form Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9927359.1 | 1999-11-19 | ||
| GBGB9927359.1A GB9927359D0 (en) | 1999-11-19 | 1999-11-19 | Improvements in or relating to organic compositions |
| US17620800P | 2000-01-14 | 2000-01-14 | |
| US60/176,208 | 2000-01-14 | ||
| PCT/GB2000/004372 WO2001035942A2 (en) | 1999-11-19 | 2000-11-17 | Analgesic compositions containing buprenorphine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003514013A JP2003514013A (ja) | 2003-04-15 |
| JP2003514013A5 true JP2003514013A5 (enExample) | 2007-09-27 |
| JP4745576B2 JP4745576B2 (ja) | 2011-08-10 |
Family
ID=26316086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001537935A Expired - Fee Related JP4745576B2 (ja) | 1999-11-19 | 2000-11-17 | 医薬組成物 |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US6995169B2 (enExample) |
| EP (1) | EP1242087B1 (enExample) |
| JP (1) | JP4745576B2 (enExample) |
| KR (1) | KR100726699B1 (enExample) |
| CN (1) | CN100431543C (enExample) |
| AR (1) | AR031682A1 (enExample) |
| AT (1) | ATE262335T1 (enExample) |
| AU (1) | AU777259B2 (enExample) |
| BR (1) | BR0015580A (enExample) |
| CA (1) | CA2392013C (enExample) |
| CO (1) | CO5261517A1 (enExample) |
| CZ (1) | CZ303160B6 (enExample) |
| DE (1) | DE60009346T2 (enExample) |
| DK (1) | DK1242087T3 (enExample) |
| ES (1) | ES2214334T3 (enExample) |
| GB (1) | GB2356348B (enExample) |
| HU (1) | HU229565B1 (enExample) |
| IL (2) | IL149580A0 (enExample) |
| MX (1) | MXPA02004978A (enExample) |
| NO (1) | NO321965B1 (enExample) |
| NZ (1) | NZ519023A (enExample) |
| PL (1) | PL199727B1 (enExample) |
| PT (1) | PT1242087E (enExample) |
| RO (1) | RO121174B1 (enExample) |
| RU (1) | RU2255737C2 (enExample) |
| SI (1) | SI21025B (enExample) |
| SK (1) | SK286888B6 (enExample) |
| TR (1) | TR200400653T4 (enExample) |
| TW (1) | TW550070B (enExample) |
| WO (1) | WO2001035942A2 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR031682A1 (es) * | 1999-11-19 | 2003-10-01 | Reckitt Benckiser Helthcare Uk | Composiciones farmaceuticas |
| US20150031718A1 (en) * | 2001-08-06 | 2015-01-29 | Purdue Pharma L.P. | Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent |
| US20030068375A1 (en) | 2001-08-06 | 2003-04-10 | Curtis Wright | Pharmaceutical formulation containing gelling agent |
| US7666876B2 (en) * | 2002-03-19 | 2010-02-23 | Vernalis (R&D) Limited | Buprenorphine formulations for intranasal delivery |
| GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
| RU2350327C2 (ru) | 2003-04-29 | 2009-03-27 | Ориксиджен Серапьютикс, Инкорпорэйтд | Составы, вызывающие потерю веса |
| DK1765292T3 (en) | 2004-06-12 | 2018-01-02 | Collegium Pharmaceutical Inc | ABUSE PREVENTIONAL PHARMACEUTICAL FORMULATIONS |
| EP1951212A2 (en) | 2005-11-22 | 2008-08-06 | Orexigen Therapeutics, Inc. | Compositions and methods for increasing insulin sensitivity |
| WO2007089318A2 (en) * | 2005-11-23 | 2007-08-09 | Orexigen Therapeutics, Inc. | Compositions and methods for reducing food cravings |
| US8916195B2 (en) * | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
| EP1897543A1 (en) | 2006-08-30 | 2008-03-12 | Euro-Celtique S.A. | Buprenorphine- wafer for drug substitution therapy |
| CA2674915C (en) | 2006-10-17 | 2015-06-30 | Penick Corporation | Process for preparing oxymorphone |
| US20080125592A1 (en) * | 2006-10-17 | 2008-05-29 | Penick Corporation | Process for preparing oxymorphone, naltrexone, and buprenorphine |
| EP2089010A1 (en) | 2006-10-24 | 2009-08-19 | The John Hopkins University | Rapid release mini-tablets provide analgesia in laboratory animals |
| CA2668885C (en) * | 2006-11-09 | 2016-08-02 | Orexigen Therapeutics, Inc. | Methods for administering weight loss medications |
| US20080199407A1 (en) | 2007-02-15 | 2008-08-21 | Slater Kenneth C | Drug Detoxification Protocol Using Microdosing |
| GB2447015A (en) | 2007-03-01 | 2008-09-03 | Reckitt Benckiser Healthcare | Analgesic composition comprising a specific ratio of buprenorphine and naltrexone |
| GB2447013A (en) * | 2007-03-01 | 2008-09-03 | Reckitt Benckiser Healthcare | Analgesic composition containing buprenorphone and nalmefene |
| GB2447014A (en) | 2007-03-01 | 2008-09-03 | Reckitt Benckiser Healthcare | Analgesic composition comprising a specific ratio of buprenorphine and naltrexone |
| GB2447016A (en) * | 2007-03-01 | 2008-09-03 | Reckitt Benckiser Healthcare | Buprenorphine/naloxone compositions |
| WO2009032246A2 (en) | 2007-09-03 | 2009-03-12 | Nanotherapeutics, Inc. | Particulate compositions for delivery of poorly soluble drugs |
| US20090082383A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched buprenorphine |
| EP2303025A4 (en) | 2008-05-30 | 2012-07-04 | Orexigen Therapeutics Inc | METHOD FOR TREATING DIGITAL FAT SWITCHES |
| US8475832B2 (en) | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
| US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| EP3659604A1 (en) * | 2010-01-11 | 2020-06-03 | Nalpropion Pharmaceuticals, Inc. | Methods of providing weight loss therapy in patients with major depression |
| CA2991216C (en) | 2010-12-22 | 2020-04-28 | Purdue Pharma L.P. | Encased tamper resistant controlled release dosage forms |
| PH12013501345A1 (en) | 2010-12-23 | 2022-10-24 | Purdue Pharma Lp | Tamper resistant solid oral dosage forms |
| MY185284A (en) | 2011-09-19 | 2021-04-30 | Orexo Ab | New abuse-resistant pharmaceutical composition for the treatment of opioid dependence |
| PT3730132T (pt) | 2012-06-06 | 2022-08-16 | Nalpropion Pharmaceuticals Llc | Composição para utilização num método de tratamento de excesso de peso e obesidade em doentes com alto risco cardiovascular |
| CA2899455C (en) | 2013-01-30 | 2021-06-08 | Pharmorx Therapeutics, Inc. | Treatments for depression and other diseases with a low dose agent |
| US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
| ES2802976T3 (es) | 2013-09-10 | 2021-01-22 | Fresh Cut Dev Llc | Pulverizador de buprenorfina sublingual |
| US8969371B1 (en) | 2013-12-06 | 2015-03-03 | Orexigen Therapeutics, Inc. | Compositions and methods for weight loss in at risk patient populations |
| AU2015250611A1 (en) * | 2014-04-22 | 2016-11-24 | H. Lundbeck A/S | Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders |
| US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
| WO2021158957A1 (en) * | 2020-02-05 | 2021-08-12 | Summit Biosciences Inc. | Drug products for intranasal administration and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8332556D0 (en) * | 1983-12-06 | 1984-01-11 | Reckitt & Colmann Prod Ltd | Analgesic compositions |
| GB8430109D0 (en) | 1984-11-29 | 1985-01-09 | Gkn Technology Ltd | Securing components |
| GB8430346D0 (en) * | 1984-11-30 | 1985-01-09 | Reckitt & Colmann Prod Ltd | Analgesic compositions |
| GB8728294D0 (en) * | 1987-12-03 | 1988-01-06 | Reckitt & Colmann Prod Ltd | Treatment compositions |
| GB2213058B (en) * | 1987-12-03 | 1991-07-17 | Reckitt & Colmann Prod Ltd | Compositions comprising buprenorphine and naltrexone for treatment of opiate addicts |
| US20010006967A1 (en) * | 1992-09-21 | 2001-07-05 | Stanley M. Crain | Method of simultaneously enhancing analgesic potency and attenuating adverse side effects caused by tramadol and other bimodally-acting opioid agonists |
| US5472943A (en) * | 1992-09-21 | 1995-12-05 | Albert Einstein College Of Medicine Of Yeshiva University, | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists |
| US5580876A (en) * | 1992-09-21 | 1996-12-03 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
| US5512578A (en) * | 1992-09-21 | 1996-04-30 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists |
| RU2077326C1 (ru) * | 1992-12-29 | 1997-04-20 | Ярыгин Владимир Никитич | Препарат для анальгезии |
| AR031682A1 (es) * | 1999-11-19 | 2003-10-01 | Reckitt Benckiser Helthcare Uk | Composiciones farmaceuticas |
| AU2001259458B2 (en) * | 2000-05-05 | 2006-09-14 | Albert Einstein College Of Medicine Of Yeshiva University | Opioid antagonist compositions and dosage forms |
-
2000
- 2000-11-16 AR ARP000106062A patent/AR031682A1/es unknown
- 2000-11-17 CA CA002392013A patent/CA2392013C/en not_active Expired - Fee Related
- 2000-11-17 DE DE60009346T patent/DE60009346T2/de not_active Expired - Lifetime
- 2000-11-17 CO CO00087459A patent/CO5261517A1/es active IP Right Grant
- 2000-11-17 MX MXPA02004978A patent/MXPA02004978A/es active IP Right Grant
- 2000-11-17 AT AT00977658T patent/ATE262335T1/de active
- 2000-11-17 SK SK876-2002A patent/SK286888B6/sk not_active IP Right Cessation
- 2000-11-17 DK DK00977658T patent/DK1242087T3/da active
- 2000-11-17 BR BR0015580-2A patent/BR0015580A/pt not_active Application Discontinuation
- 2000-11-17 AU AU15297/01A patent/AU777259B2/en not_active Ceased
- 2000-11-17 RU RU2002116361/15A patent/RU2255737C2/ru not_active IP Right Cessation
- 2000-11-17 ES ES00977658T patent/ES2214334T3/es not_active Expired - Lifetime
- 2000-11-17 JP JP2001537935A patent/JP4745576B2/ja not_active Expired - Fee Related
- 2000-11-17 SI SI200020061A patent/SI21025B/sl not_active IP Right Cessation
- 2000-11-17 EP EP00977658A patent/EP1242087B1/en not_active Expired - Lifetime
- 2000-11-17 IL IL14958000A patent/IL149580A0/xx active IP Right Grant
- 2000-11-17 HU HU0203588A patent/HU229565B1/hu not_active IP Right Cessation
- 2000-11-17 KR KR1020027006375A patent/KR100726699B1/ko not_active Expired - Fee Related
- 2000-11-17 PT PT00977658T patent/PT1242087E/pt unknown
- 2000-11-17 RO ROA200200620A patent/RO121174B1/ro unknown
- 2000-11-17 NZ NZ519023A patent/NZ519023A/en not_active IP Right Cessation
- 2000-11-17 PL PL355330A patent/PL199727B1/pl unknown
- 2000-11-17 CN CNB008159181A patent/CN100431543C/zh not_active Expired - Fee Related
- 2000-11-17 GB GB0028088A patent/GB2356348B/en not_active Expired - Fee Related
- 2000-11-17 TR TR2004/00653T patent/TR200400653T4/xx unknown
- 2000-11-17 CZ CZ20022121A patent/CZ303160B6/cs not_active IP Right Cessation
- 2000-11-17 WO PCT/GB2000/004372 patent/WO2001035942A2/en not_active Ceased
-
2001
- 2001-01-29 TW TW090101624A patent/TW550070B/zh not_active IP Right Cessation
-
2002
- 2002-05-09 IL IL149580A patent/IL149580A/en not_active IP Right Cessation
- 2002-05-14 US US10/145,284 patent/US6995169B2/en not_active Expired - Fee Related
- 2002-05-15 NO NO20022330A patent/NO321965B1/no not_active IP Right Cessation
-
2005
- 2005-10-20 US US11/254,602 patent/US7402591B2/en not_active Expired - Fee Related
- 2005-10-20 US US11/254,988 patent/US20060058333A1/en not_active Abandoned
- 2005-10-20 US US11/254,525 patent/US20060069113A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003514013A5 (enExample) | ||
| RU2002116361A (ru) | Анальгезирующие композиции, содержащие бупренорфин | |
| JP2010520186A5 (enExample) | ||
| WO2000021515A3 (en) | Intranasal codeine for the rapid suppression of cough and rapid relief of pain | |
| MX2009009131A (es) | Mejoras en y con relacion a composiciones medicinales. | |
| JP2009544619A5 (enExample) | ||
| JP2010520185A5 (enExample) | ||
| CA2661759A1 (en) | Buprenophine-wafer for drug substitution therapy | |
| CA2359812A1 (en) | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures | |
| US20110082167A1 (en) | Topical compositions of opioid antagonists and methods for treating skin conditions therewith | |
| GB2316004A (en) | Novel formulations for transdermal delivery of pergolide | |
| WO2003045437A8 (en) | Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene | |
| AUPN603895A0 (en) | Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids | |
| WO2002094273A3 (en) | Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways | |
| JP2009536147A5 (enExample) | ||
| MX2009009132A (es) | Composiciones medicinales mejoradas que comprenden buprenorfina y naltrexona. | |
| WO2001093852A3 (en) | Method of treating pain using nalbuphine and opioid antagonists | |
| JP2004507496A5 (enExample) | ||
| MX2009009133A (es) | Composiciones medicinales mejoradas que comprenden buprenorfina y naloxona. | |
| JP2002523370A5 (enExample) | ||
| WO2003073981A3 (en) | Novel of cytokine inhibitors | |
| JP2010520184A5 (enExample) | ||
| JP2004537500A5 (enExample) | ||
| JP2002528502A5 (enExample) | ||
| RU2004107501A (ru) | Способ лечения алкоголизма или злоупотребления алкоголем |